Jürgen Wolf

1984–2026 年に発表

129
論文数
30,104
被引用数
80
h 指数
113
i10 指数

被引用数

Jürgen Wolf の年別被引用数1976 年: 被引用 1 件1984 年: 被引用 1 件1986 年: 被引用 1 件1987 年: 被引用 2 件1988 年: 被引用 1 件1989 年: 被引用 1 件1990 年: 被引用 1 件1991 年: 被引用 2 件1993 年: 被引用 1 件1994 年: 被引用 5 件1995 年: 被引用 2 件1996 年: 被引用 1 件1997 年: 被引用 3 件1998 年: 被引用 5 件1999 年: 被引用 8 件2000 年: 被引用 10 件2001 年: 被引用 10 件2002 年: 被引用 40 件2003 年: 被引用 65 件2004 年: 被引用 51 件2005 年: 被引用 67 件2006 年: 被引用 56 件2007 年: 被引用 52 件2008 年: 被引用 50 件2009 年: 被引用 67 件2010 年: 被引用 72 件2011 年: 被引用 105 件2012 年: 被引用 142 件2013 年: 被引用 245 件2014 年: 被引用 240 件2015 年: 被引用 329 件2016 年: 被引用 486 件2017 年: 被引用 465 件2018 年: 被引用 419 件2019 年: 被引用 1,128 件2020 年: 被引用 1,217 件2021 年: 被引用 1,321 件2022 年: 被引用 1,155 件2023 年: 被引用 977 件2024 年: 被引用 1,667 件2025 年: 被引用 875 件2026 年: 被引用 21 件1977〜1983 年は被引用が無いため表示していません1985 年は被引用が無いため表示していません1992 年は被引用が無いため表示していません

引用元

国・地域

この著者を引用した国・地域の世界地図アメリカ合衆国: 引用元論文 4,056 件、この内訳の 26.3%中国: 引用元論文 1,715 件、この内訳の 11.2%ドイツ: 引用元論文 1,020 件、この内訳の 6.6%イタリア: 引用元論文 870 件、この内訳の 5.7%イギリス: 引用元論文 821 件、この内訳の 5.3%フランス: 引用元論文 730 件、この内訳の 4.8%日本: 引用元論文 634 件、この内訳の 4.1%スペイン: 引用元論文 605 件、この内訳の 3.9%オランダ: 引用元論文 461 件、この内訳の 3%カナダ: 引用元論文 450 件、この内訳の 2.9%スイス: 引用元論文 387 件、この内訳の 2.5%韓国: 引用元論文 374 件、この内訳の 2.4%
0%26.3%その他 21.3%

分野

  • Medicine64.9%
  • Biochemistry, Genetics and Molecular Biology27%
  • Engineering2.7%
  • Immunology and Microbiology1.8%
  • Computer Science1.4%
  • Mathematics0.4%
  • その他1.8%

トピック

  • Lung Cancer Treatments and Mutations10%
  • Lung Cancer Research Studies7.3%
  • Cancer Immunotherapy and Biomarkers5%
  • Cancer Genomics and Diagnostics4.7%
  • Neuroendocrine Tumor Research Advances2.5%
  • Lung Cancer Diagnosis and Treatment2.1%
  • その他68.4%

共著者

全論文

検索で開く
  1. Sotorasib for Lung Cancers with KRAS p.G12C Mutation

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2021 被引用: 1,769

  2. Comprehensive genomic profiles of small cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Danila Seidel, Berit Pinther, Philipp Schaub, Christian Becker, Janine Altmüller, Jun Yokota, Takashi Kohno, Reika Iwakawa, Koji Tsuta, Masayuki Noguchi, Thomas Muley, Hans Hoffmann, Philipp A. Schnabel, Iver Petersen, Yuan Chen, Alex Soltermann, Verena Tischler, Chang‐Min Choi, Yong‐Hee Kim, Pierre P. Massion, Yong Zou, Dragana J. Jovanović, Milica Kontić, Gavin Wright, Prudence A. Russell, Benjamin Solomon, Ina Koch, Michael Lindner, Lucia Anna Muscarella, Annamaria la Torre, John K. Field, Marko Jakopović, Jelena Knežević, Esmeralda Castaños‐Vélez, Luca Roz, Ugo Pastorino, O.T. Brustugun, Marius Lund‐Iversen, Erik Thunnissen, Jens Köhler, Martin Schüler, Johan Botling, Martin Sandelin, Montse Sánchez‐Céspedes, Helga B. Salvesen, Viktor Achter, Ulrich Lang, Magdalena Bogus, Peter M. Schneider, Thomas Zander, Sascha Ansén, Michael Hallek, Jürgen Wolf, Martin Vingron, Yasushi Yatabe, William D. Travis, Peter Nürnberg, Christian Reinhardt, Sven Perner, Lukas C. Heukamp, Reinhard Büttner, Stefan A. Haas, Élisabeth Brambilla, Martin Peifer, Julien Sage, Roman K. Thomas - Nature 2015 被引用: 2,428

  3. Sotorasib versus docetaxel for previously treated non-small-cell lung cancer with KRASG12C mutation: a randomised, open-label, phase 3 trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , David Waterhouse, Luis Paz‐Ares - The Lancet 2023 被引用: 566

  4. Tarlatamab for Patients with Previously Treated Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 482

  5. Capmatinib in MET Exon 14–Mutated or MET -Amplified Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Mikhail Akimov, Rebecca S. Heist - New England Journal of Medicine 2020 被引用: 997

  6. Tumour-agnostic efficacy and safety of selpercatinib in patients with RET fusion-positive solid tumours other than lung or thyroid tumours (LIBRETTO-001): a phase 1/2, open-label, basket trial

    著者: , , , , , , , , , , , , , , - The Lancet Oncology 2022 被引用: 420

  7. Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Karen L. Reckamp, Grace K. Dy, Jürgen Wolf, Benjamin Solomon, Gerald S. Falchook, Kevin Ebata, Michele Nguyen, Binoj C. Nair, Edward Y. Zhu, Luxi Yang, Xin Huang, Elizabeth Olek, S. Michael Rothenberg, Kōichi Goto, Vivek Subbiah - New England Journal of Medicine 2020 被引用: 836

  8. Vemurafenib in Multiple Nonmelanoma Cancers with BRAF V600 Mutations

    著者: , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2015 被引用: 1,734

  9. Mapping the Hallmarks of Lung Adenocarcinoma with Massively Parallel Sequencing

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Kristin Thompson, Wendy Winckler, David J. Kwiatkowski, Bruce E. Johnson, Pasi A. Jänne, Vincent A. Miller, William Pao, William D. Travis, Harvey I. Pass, Stacey Gabriel, Eric S. Lander, Roman K. Thomas, Levi A. Garraway, Gad Getz, Matthew Meyerson - Cell 2012 被引用: 1,840

  10. Repotrectinib in ROS1 Fusion–Positive Non–Small-Cell Lung Cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Gregory E. Sims, Yong Yuan, Byoung Chul Cho - New England Journal of Medicine 2024 被引用: 210

  11. Integrative genome analyses identify key somatic driver mutations of small-cell lung cancer

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Shantanu Banerji, Gad Getz, Kwon-Sik Park, Daniel Rauh, Christian Grütter, Matthias Fischer, Laura Pasqualucci, Gavin Wright, Zoe Wainer, Prudence A. Russell, Iver Petersen, Yuan Chen, Erich Stoelben, Corinna Ludwig, Philipp A. Schnabel, Hans Hoffmann, Thomas Muley, Michael Brockmann, Walburga Engel-Riedel, Lucia Anna Muscarella, Vito Michele Fazio, Harry J.M. Groen, Wim Timens, Hannie Sietsma, Erik Thunnissen, Egbert F. Smit, Daniëlle A.M. Heideman, Peter J.F. Snijders, Federico Cappuzzo, Claudia Ligorio, Stefania Damiani, John K. Field, Steinar Solberg, Odd Terje Brustugun, Marius Lund‐Iversen, Jörg Sänger, Joachim H. Clement, Alex Soltermann, Holger Moch, Walter Weder, Benjamin Solomon, Jean‐Charles Soria, Pierre Validire, Benjamin Besse, Élisabeth Brambilla, Christian Brambilla, Sylvie Lantuéjoul, Philippe Lorimier, Peter M. Schneider, Michael Hallek, William Pao, Matthew Meyerson, Julien Sage, Jay Shendure, Robert C. Schneider, Reinhard Büttner, Jürgen Wolf, Peter Nürnberg, Sven Perner, Lukas C. Heukamp, Paul K. Brindle, Stefan A. Haas, Roman K. Thomas - Nature Genetics 2012 被引用: 1,418

  12. First-Line Selpercatinib or Chemotherapy and Pembrolizumab in RET Fusion–Positive NSCLC

    著者: , , , , , , , , , , , , , , , , , , , , , , , - New England Journal of Medicine 2023 被引用: 213

  13. Long-Term Outcomes and Molecular Correlates of Sotorasib Efficacy in Patients With Pretreated KRAS G12C-Mutated Non–Small-Cell Lung Cancer: 2-Year Analysis of CodeBreaK 100

    著者: , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2023 被引用: 149

  14. Selpercatinib in Patients With RET Fusion–Positive Non–Small-Cell Lung Cancer: Updated Safety and Efficacy From the Registrational LIBRETTO-001 Phase I/II Trial

    著者: , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2022 被引用: 205

  15. Entrectinib in ROS1 fusion-positive non-small-cell lung cancer: integrated analysis of three phase 1–2 trials

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Brian Simmons, Na Cui, Ann Johnson, Susan Eng, Timothy R. Wilson, Robert C. Doebele - The Lancet Oncology 2019 被引用: 537

  16. Efficacy and Safety of Rovalpituzumab Tesirine in Third-Line and Beyond Patients with DLL3-Expressing, Relapsed/Refractory Small-Cell Lung Cancer: Results From the Phase II TRINITY Study

    著者: , , , , , , , , , , , , , , , - Clinical Cancer Research 2019 被引用: 322

  17. Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , - The Lancet Oncology 2015 被引用: 1,429

  18. The evolving landscape of biomarker testing for non-small cell lung cancer in Europe

    著者: , , , , , , , , , - Lung Cancer 2021 被引用: 201

  19. Evolutionary trajectories of small cell lung cancer under therapy

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Clemens Aigner, Thomas Elter, Karin Toepelt, Yon‐Dschun Ko, S Kurz, Christian Grohé, Monika Serke, Katja Höpker, Lars Hagmeyer, Fabian Doerr, Khosro Hekmath, Judith Strapatsas, K Kambartel, Geothy Chakupurakal, Annette Busch, Franz‐Georg Bauernfeind, Frank Griesinger, Anne Luers, Wiebke Dirks, Rainer Wiewrodt, Andrea Luecke, Ernst Rodermann, Andreas Diel, Volker Hagen, K. Severin, Roland T. Ullrich, Hans Christian Reinhardt, Alexander Quaas, Magdalena Bogus, Cornelius Courts, Peter Nürnberg, Kerstin Becker, Viktor Achter, Reinhard Büttner, Jürgen Wolf, Martin Peifer, Roman K. Thomas - Nature 2024 被引用: 105

  20. BRAF Inhibition in BRAF V600 -Mutant Gliomas: Results From the VE-BASKET Study

    著者: , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2018 被引用: 331

  21. Vemurafenib for BRAF V600–Mutant Erdheim-Chester Disease and Langerhans Cell Histiocytosis

    著者: , , , , , , , , , , , , , , , , , , , , , - JAMA Oncology 2017 被引用: 405

  22. Evaluation of BGJ398, a Fibroblast Growth Factor Receptor 1-3 Kinase Inhibitor, in Patients With Advanced Solid Tumors Harboring Genetic Alterations in Fibroblast Growth Factor Receptors: Results of a Global Phase I, Dose-Escalation and Dose-Expansion Study

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , - Journal of Clinical Oncology 2017 被引用: 435

  23. Integrative genomic profiling of large-cell neuroendocrine carcinomas reveals distinct subtypes of high-grade neuroendocrine lung tumors

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Denis Moro‐Sibilot, Christian Brambilla, Sylvie Lantuéjoul, Nicolas Lemaître, Alex Soltermann, Walter Weder, Verena Tischler, Odd Terje Brustugun, Marius Lund‐Iversen, Åslaug Helland, Steinar Solberg, Sascha Ansén, Gavin Wright, Benjamin Solomon, Luca Roz, Ugo Pastorino, Iver Petersen, Joachim H. Clement, Jörg Sänger, Jürgen Wolf, Martin Vingron, Thomas Zander, Sven Perner, William D. Travis, Stefan A. Haas, Magali Olivier, Matthieu Foll, Reinhard Büttner, D. Neil Hayes, Élisabeth Brambilla, Lynnette Fernandez‐Cuesta, Roman K. Thomas - Nature Communications 2018 被引用: 373

  24. K-ras Mutation Subtypes in NSCLC and Associated Co-occuring Mutations in Other Oncogenic Pathways

    著者: , , , , , , , , , , , , , , , , , , , , , , , , , , , , , , Christian Grohé, Anna Eisert, Rieke Frank, Leonie Gogl, Carsten Schaepers, Alessandra Holzem, Martin Hellmich, Roman K. Thomas, Martin Peifer, Martin L. Sos, Reinhard Büttner, Jürgen Wolf - Journal of Thoracic Oncology 2018 被引用: 259